We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of an Intervention Program for the Prevention of Anemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00436202
Recruitment Status : Unknown
Verified September 2010 by Wolfson Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : February 16, 2007
Last Update Posted : September 14, 2010
Sponsor:
Collaborator:
Tel Aviv District of the Health Office
Information provided by:
Wolfson Medical Center

Brief Summary:
The purpose of the study is to determine whether improvement in the accessibility to iron supplement will decrease anemia rates in infants.

Condition or disease Intervention/treatment
Anemia Behavioral: Iron supplement

Detailed Description:

Iron deficiency anemia is the most common type of anemia in infants, children and women of reproductive age. The most frequent cause of iron deficiency in infants at 6 months of life is poor nutrition during a period of rapid growth and a diet lacking in iron rich foods. Children who suffered from anemia in infancy demonstrated slower cognitive development, were low achievers in school and had a high rate of behavioral disturbances.

The Ministry of Health implements a primary prevention program for anemia. If by making iron supplements more accessible would increase parental compliance in acquisition of the iron supplement and subsequently reduce the rate of iron deficiency anemia, the result would be the immediate application of the finding. It is possible to implement a program whereby the supplement will be directly available at the family health centers for purchase by the parent.


Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anemia Iron
U.S. FDA Resources





Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Months and older   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Infant who visit Family Health Centers

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00436202


Locations
Israel
Tel Aviv District of the Health Office
Tel Aviv, Israel
Sponsors and Collaborators
Wolfson Medical Center
Tel Aviv District of the Health Office
Investigators
Principal Investigator: Tamar Shohat, M.D., MPH Tel Aviv District of the Health Office

ClinicalTrials.gov Identifier: NCT00436202     History of Changes
Other Study ID Numbers: Anemia
First Posted: February 16, 2007    Key Record Dates
Last Update Posted: September 14, 2010
Last Verified: September 2010

Keywords provided by Wolfson Medical Center:
Anemia
Iron
Supplement

Additional relevant MeSH terms:
Anemia
Hematologic Diseases